Removing Restrictions to Germline Testing
With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?
With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.
New molecular tests and diagnostic support technologies can help labs detect sepsis earlier, faster, and with greater accuracy
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?
Artificial intelligence models have a valuable role to play in each phase of the total testing process.
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.
Juan Antonio Retamero, MD, shares his thoughts on recent trends in AI and digital pathology, and how they may progress.
Artificial intelligence won’t take your job—but what are the real concerns around healthcare AI and its use?